-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Ribozymes as Tools for Therapeutic Target Validation in Arthritis
Veröffentlicht in The Journal of immunology (1950)
VolltextArtikel -
9
-
10
Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA
Veröffentlicht in Nucleic acids research
VolltextArtikel -
11
Inhibition of replication of an HCV-poliovirus chimera in cell culture using a novel ribozyme motif: the Zinzyme™: Dennis G Macejak, Kristi L Jensen, Shawn P Zinnen, Victor Mokler, Pamela A Pavco, Lawrence M Blatt, Ribozyme Pharmaceuticals Inc, Boulder, CO
Veröffentlicht in Hepatology (Baltimore, Md.)
VolltextArtikel -
12
-
13
Nuclease-resistant ribozymes targeting the minus strand of hepatitis C virus (HCV) RNA can inhibit the replication of a chimeric virus in cell culture: Dennis G Macejak, Kristi L Jensen, Victor Mokler, Pamela A Pavco, Lawrence M Blatt, Ribozyme Pharmaceuticals Inc, Boulder, CO
Veröffentlicht in Hepatology (Baltimore, Md.)
VolltextArtikel -
14
Combinatio of hepbzyme™, an anti-HBV nuclease resistant ribozyme, with lamivudine or interferon impoves inhibition of HBV replication in cell culture: DAvid V Morrissey, Stacey L Overly, Daivd A Johnson, Vicor Mokler, Pamela A Pavco, Lawrence M Blatt, Ribozyme Pharmaceuticals, Inc, Boulder, CO
Veröffentlicht in Hepatology (Baltimore, Md.)
VolltextArtikel -
15
-
16
Bioactivity of anti-angiogenic ribozymes targetingFlt-1andKDRmRNA
Veröffentlicht in Nucleic acids research
VolltextArtikel -
17
-
18
-
19
-
20